Regional citrate anticoagulation during hemodialysis: A simplified procedure using duocart biofiltration

Blood Purification

Volumn 23, Issue 6, 2005, Pages 473-480

  Ridel, Christophe ^a,c   Mercadal, Lucile ^a   Béné, Bernard ^b   Hamani, Abdelaziz ^a   Deray, Gilbert ^a   Petitclerc, Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hospal R and D Int   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Biofiltration; Citrate anticoagulation; Hemodialysis; Ionic dialysance

Indexed keywords

CALCIUM; CALCIUM ION; CITRIC ACID; GLUCOSE; MAGNESIUM; POTASSIUM;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ARTIFICIAL KIDNEY; BIOFILTRATION; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CITRATES; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 29144482671     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089652     Document Type: Article

References (33)

1. Morita Y, Johnson R, Dorn R, Hall D: Regional anticoagulation during hemodialysis using citrate. Am J Med 1961;242:32-42.
2. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983;308:258-266.
3. Flanigan MJ, von Brecht J, Freeman RM, Lim VS: Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation. Am J Kidney Dis 1987;9:147-153.
4. Van der Meulen J, Janssen MJ, Langendijk PN, et al: Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis. Clin Nephrol 1992;37:36-41.
5. Ward DM: The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Renal Replace Ther 1997;4:160-173.
6. Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS: Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A. Am J Kidney Dis 1996;27:519-524.
7. Apsner R, Buchmayer H, Lang T, et al: Simplified citrate anticoagulation for high-flux hemodialysis. Am J Kidney Dis 2001;38:979-987.
8. Evenepoel P, Maes B, Vanwalleghem J, et al: Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate. Am J Kidney Dis 2002;39:315-323.
9. Kelleher SP, Schulman G: Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis 1987;9:235-236.
10. Silverstein FJ, Oster JR, Perez GO, et al: Metabolic alkalosis induced by regional citrate hemodialysis. ASAIO Trans 1989;35:22-25.
11. Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD: Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999;33:E8.
12. Charney DI, Salmond R: Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis. ASAIO Trans 1990;36:M217-M219.
13. Mercadal L, Petitclerc T, Bene B, et al: Duocart biofiltration: a new method of hemodialysis. ASAIO J 1999;45:151-156.
14. Janssen MJ, Deegens JK, Kapinga TH, et al: Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients. Kidney Int 1996;49:806-813.
15. Lindsay RM, Bene B, Goux N, et al: Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis. Am J Kidney Dis 2001;38:565-574.
16. Mercadal L, Tezenas du Montcel S, Jaudon MC, et al: Ionic dialysance vs urea clearance in the absence of cardiopulmonary recirculation. Nephrol Dial Transplant 2002;17:106-111.
17. Petitclerc T: Recent developments in conductivity monitoring of haemodialysis session. Nephrol Dial Transplant 1999;14:2607-2613.
18. Saltissi D, Morgan C, Westhuyzen J, Healy H: Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation. Nephrol Dial Transplant 1999;14:2698-2703.
19. Calatzis A, Toepfer M, Schramm W, et al: Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 2001;89:233-236.
20. McIntyre CW, Lambie SH, Taal MW, Fluck RJ: Assessment of haemodialysis adequacy by ionic dialysance: intra-patient variability of delivered treatment. Nephrol Dial Transplant 2003;18:559-563.
21. Movilli E, Camerini C, Zein H, et al: A prospective comparison of bicarbonate dialysis, hemodiafiltration and acetate-free biofiltration in the elderly. Am J Kidney Dis 1996;27:541-547.
22. Todeschini M, Macconi D, Fernandez NG, et al: Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. Am J Kidney Dis 2002;40:783-793.
23. Renaux JL, Thomas M, Crost T, et al: Activation of the kallicrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution and pH. Kidney Int 1999;55:1097-1103.
24. Keller F, Seemann J, Preuschof L, Offermann G: Risk factors of system clotting in heparin-free haemodialysis. Nephrol Dial Transplant 1990;5:802-807.
25. Swartz RD, Port FK: Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin. Kidney Int 1979;16:513-518.
26. Maher JF, Lapierre L, Schreiner GE, et al: Regional heparinization for hemodialysis: technical and clinical experiences. N Engl J Med 1963;268:451-456.
27. Zusman RM, Rubin RH, Cato AE, et al: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 1981;304:934-939.
28. Vanholder RC, Camez AA, Veys NM, et al: Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis. Kidney Int 1994;45:1754-1759.
29. Vienken J, Diamantoglou M, Hahn C, et al: Considerations on developmental aspects of biocompatible dialysis membranes. Artif Organs 1995;19:398-406.
30. Charney DI, Salmond R: Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis. ASAIO Trans 1990;12:375-382.
31. Bohler J, Schollmeyer P, Dressel B, et al: Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996;7:234-241.
32. Dhondt A, Vanholder R, Tielemans C, et al: Effect of regional citrate anticoagulation on leukopenia, complement activation and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membrane. Nephron 2000;85:334-342.
33. Hofbauer R, Moser D, Frass M, et al: Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999;56:1578-1583.